{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T07:42:09Z","timestamp":1698651729880},"reference-count":21,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2004,12,1]],"date-time":"2004-12-01T00:00:00Z","timestamp":1101859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2004,12]]},"DOI":"10.1016\/j.humpath.2004.09.013","type":"journal-article","created":{"date-parts":[[2004,12,22]],"date-time":"2004-12-22T01:34:55Z","timestamp":1103679295000},"page":"1524-1530","source":"Crossref","is-referenced-by-count":9,"title":["p16 expression in sentinel nodes with metastatic breast carcinoma: Evaluation of its role in developing triaging strategies for axillary node dissection and a marker of poor prognosis"],"prefix":"10.1016","volume":"35","author":[{"given":"Meenakshi","family":"Singh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikelle B.","family":"Parnes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"Spoelstra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle J.","family":"Bleile","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William A.","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2004.09.013_BIB1","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1056\/NEJMoa012782","article-title":"A randomized comparison of sentinel node biopsy with routine axillary dissection in breast cancer","volume":"349","author":"Veronesi","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.humpath.2004.09.013_BIB2","series-title":"AJCC Cancer Staging Manual","first-page":"221","year":"2002"},{"key":"10.1016\/j.humpath.2004.09.013_BIB3","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/1097-0142(20000801)89:3<574::AID-CNCR12>3.0.CO;2-Y","article-title":"Pathologic features associated with nonsentinel lymph node metastases in patients with metastatic breast carcinoma in a sentinel lymph node","volume":"89","author":"Turner","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2004.09.013_BIB4","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1097\/00000658-199904000-00013","article-title":"Do all patients with sentinel node metastasis from breast carcinoma need complete axillary node dissection","volume":"229","author":"Chu","year":"1999","journal-title":"Ann Surg"},{"key":"10.1016\/j.humpath.2004.09.013_BIB5","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1002\/cncr.11803","article-title":"Clinicopathologic features of metastasis in nonsentinel lymph nodes of breast carcinoma","volume":"98","author":"Degnim","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2004.09.013_BIB6","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1245\/ASO.2003.05.020","article-title":"Clinicopathologic factors predicting involvement of nonsentinel axillary nodes in women with breast cancer","volume":"10","author":"Hwang","year":"2003","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.humpath.2004.09.013_BIB7","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/00008390-200306000-00002","article-title":"The effect of flavopiridol on the growth of p16+ and p16- melanoma cell lines","volume":"13","author":"Robinson","year":"2003","journal-title":"Melanoma Res"},{"key":"10.1016\/j.humpath.2004.09.013_BIB8","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1093\/jnci\/93.6.415","article-title":"Searching for selective cyclin-dependent kinase inhibitors to target the retinoblastoma\/p16 cancer gene pathway","volume":"93","author":"Kubo","year":"2001","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.humpath.2004.09.013_BIB9","doi-asserted-by":"crossref","first-page":"11891","DOI":"10.1073\/pnas.95.20.11891","article-title":"Aberrant methylation of p16INK4a is an early event in lung cancer and a potential biomarker for early diagnosis","volume":"95","author":"Belinsky","year":"1998","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.humpath.2004.09.013_BIB10","doi-asserted-by":"crossref","first-page":"e102","DOI":"10.1136\/jmg.40.8.e102","article-title":"Identification of a splice acceptor site mutation in p16INK4A\/p14ARF within a breast cancer, melanoma, neurofibroma prone kindred","volume":"40","author":"Prowse","year":"2003","journal-title":"J Med Genet"},{"key":"10.1016\/j.humpath.2004.09.013_BIB11","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/path.1297","article-title":"Concomitant expression of p16INK4a and p14ARF in primary breast cancer and analysis of inactivation mechanisms","volume":"199","author":"Silva","year":"2003","journal-title":"J Pathol"},{"key":"10.1016\/j.humpath.2004.09.013_BIB12","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/ijc.11009","article-title":"Overexpression of Id-1 is associated with poor clinical outcome in node negative breast cancer","volume":"104","author":"Schoppmann","year":"2003","journal-title":"Int J Cancer"},{"key":"10.1016\/j.humpath.2004.09.013_BIB13","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0165-4608(00)00367-8","article-title":"Molecular analysis of the INK4A and INK4B gene loci in human breast cancer cell lines and primary carcinomas","volume":"125","author":"Bisogna","year":"2001","journal-title":"Cancer Genet Cytogen"},{"key":"10.1016\/j.humpath.2004.09.013_BIB14","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1054\/bjoc.1999.0980","article-title":"The role of p16-cyclin D\/CDK-pRb pathway in the tumorigenesis of endometrioid-type endometrial carcinoma","volume":"82","author":"Tsuda","year":"2000","journal-title":"Br J Cancer"},{"key":"10.1016\/j.humpath.2004.09.013_BIB15","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1038\/modpathol.3880172","article-title":"Abnormal expression of cell cycle regulatory proteins in ductal and lobular carcinomas of the breast","volume":"13","author":"Geradts","year":"2000","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2004.09.013_BIB16","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/(SICI)1097-0215(19980220)79:1<71::AID-IJC14>3.0.CO;2-K","article-title":"Retinoblastoma and p16 proteins in mammary carcinoma","volume":"79","author":"Dublin","year":"1998","journal-title":"Int J Cancer"},{"key":"10.1016\/j.humpath.2004.09.013_BIB17","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1023\/A:1013047413895","article-title":"P16INK4a protein expression is associated with poor survival of the breast cancer patients after CMF chemotherapy","volume":"70","author":"Han","year":"2001","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.humpath.2004.09.013_BIB18","first-page":"2777","article-title":"INK4a gene expression and methylation in primary breast cancer","volume":"6","author":"Hui","year":"2000","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.humpath.2004.09.013_BIB19","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1002\/1097-0142(20010901)92:5<1177::AID-CNCR1436>3.0.CO;2-5","article-title":"Possible associations among expression of p14(ARF), p16(INK4a), p21(WAF1\/CIP1), p27(KIP1), and p53 accumulation and the balance of apoptosis and cell proliferation in ovarian carcinomas","volume":"92","author":"Saegusa","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2004.09.013_BIB20","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1046\/j.1365-2559.2002.01465.x","article-title":"Immunohistochemical staining with MIB1, bcl2 and p16 assists in the distinction of cervical glandular intraepithelial neoplasia from tubo-endometrial metaplasia, endometriosis and microglandular hyperplasia","volume":"41","author":"Cameron","year":"2002","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2004.09.013_BIB21","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s004280050300","article-title":"P16\/MTS1 and pRb expression in endometrial carcinomas","volume":"434","author":"Milde-Langosch","year":"1999","journal-title":"Virchows Arch"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817704005350?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817704005350?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,30]],"date-time":"2019-01-30T19:52:30Z","timestamp":1548877950000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817704005350"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,12]]},"references-count":21,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2004,12]]}},"alternative-id":["S0046817704005350"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2004.09.013","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2004,12]]}}}